Lantheus Statistics
NASDAQ: LNTHHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
102.100.00 (0.00%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Lantheus by the numbers
Lantheus has a market capitalization of $6.68 billion based on 65.40M shares outstanding. Its trailing P/E ratio is 25.4, and its forward P/E is 15.3. The stock trades 1.6% above its 50-day average and 8.6% above its 200-day average.
Average daily trading volume is 1.02M shares, or about $104.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LNTH valuation vs. peer median
| Metric | LNTH | Peer median | Difference |
|---|---|---|---|
| Market cap | $6.68B | $988.42M | +576% |
| Avg. volume | 1.02M | 1.71M | -40% |
Peer median across 8 companies: ORKA, NEOG, CLDX, NTLA, QUIT, QDEL, MYGN, TKNO.
Valuation
- Market cap
- $6.68B
- P/E (TTM)
- 25.40
- Forward P/E
- 15.34
- Price / sales (latest FY)
- 4.33
- EPS (TTM)
- $4.02
- Shares outstanding
- 65.40M
Price and trading
- Previous close
- 102.10
- Open
- 102.10
- Day range
- 102.07 – 102.40
- 52-week range
- 54.94 – 111.86
- 52-week change
- +82.91%
- 50-day moving average
- 100.46
- Beta
- —
- Volume
- 1.07M
- Average volume
- 1.02M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 6.68B
- Pe
- 25.40
- Forward Pe
- 15.34
- Eps
- 4.02
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 111.86
- Week52 Low
- 54.94
- Avg Volume
- 1.02M
- Shares Outstanding
- 65.40M
- Ma50
- 100.46
- Ma200
- 94.00
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -8.73%
- Pct From52w Low
- 85.84%